humans (3)
[sdv.mhep.hem]life sciences [q-bio]/human health and pathology/hematology (2)
03 medical and health sciences (2)
0302 clinical medicine (2)
030215 immunology (2)
030220 oncology & carcinogenesis (2)
adult (2)
business (2)
business.industry (2)
cancer research (2)
fusion proteins, bcr-abl (2)
hematology (2)
imatinib mesylate (2)
internal medicine (2)
leukemia, myeloid, chronic-phase (2)
medicine (2)
medicine.disease (2)
medicine.medical_specialty (2)
neoplasm recurrence, local (2)
oncology (2)
protein kinase inhibitors (2)
remission induction (2)
treatment outcome (2)
3. good health (1)
aged (1)
antineoplastic combined chemotherapy protocols (1)
article (1)
biopsy (1)
central nervous system neoplasms (1)
chronic myelogenous leukemia (1)
computingmilieux_miscellaneous (1)
confidence interval (1)
diffuse large b-cell lymphoma (1)
discontinuation (1)
disease outcome (1)
diseases of the blood and blood-forming organs (1)
drug administration schedule (1)
female (1)
france (1)
gastroenterology (1)
gene expression regulation, leukemic (1)
hemic and lymphatic diseases (1)
imatinib (1)
kidney (1)
leukemia, myelogenous, chronic, bcr-abl positive (1)
lymphoma (1)
lymphoma, large b-cell, diffuse (1)
male (1)
medicine.anatomical_structure (1)
medicine.diagnostic_test (1)